Back to search
Extramembranous Glomerulopathy
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Extramembranous Glomerulopathy trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Extramembranous Glomerulopathy trials you may qualify forNEPTUNE Match is an additional opportunity offered to NEPTUNE study participants to prospectively recruit and communicate patient-specific clinical trial matchi…
The purpose of this study is to assess the safety, tolerability, pharmacokinetic, and efficacy of surovatamig administered by subcutaneous injection in adult pa…
In this study, researchers will learn more about the use of felzartamab in participants with primary membranous nephropathy, also known as PMN. In people with P…
To evaluate the efficacy and safety of B007 in the Treatment of Primary Membranous Nephropathy
This Phase I Clinical Study assessed the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profiles and Preliminary Efficacy of Subcutaneous Injection o…
To evaluate the safety and tolerability of three dose regimens of budoprutug in subjects with PMN
This study is a single-arm, open-label, dose-escalation and dose-expansion clinical trial, divided into two phases: the first phase is the dose-escalation phase…
This study is a single-arm, single-center, open-label, dose-escalation exploratory clinical study designed to evaluate the safety, tolerability, and preliminary…